Generalized Anxiety Disorder, Posttraumatic Stress Disorder (PTSD), Social Anxiety Disorder
Conditions
Brief summary
This is a qualitative study of participants who have taken part in a randomized controlled trial comparing transdiagnostic metacognitive therapy and disorder-specific cognitive-behavioral therapy for anxiety disorders. The purpose of the study is to explore participant perceptions of the respective treatment models to facilitate implementation and dissemination of the treatments.
Interventions
BEHAVIORALTransdiagnostic metacognitive therapy
Metacognitive therapy focuses on metacognitions.
Cognitive-behavioral therapy focuses on cognitions and/or behaviors.
Sponsors
Karolinska Institutet
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age 18 years or older, * A principal diagnosis of generalized anxiety disorder, social anxiety disorder, or posttraumatic stress disorder, * No change in dose during the last six weeks if on pharmacological treatment, and * Ability to read and speak Swedish.
Exclusion criteria
* A current diagnosis of psychotic disorder, bipolar disorder, neurocognitive disorder, or moderate to severe substance use disorder, * Acute suicide risk, or * Concurrent psychological treatment.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Qualitative interview data | Up to 13 weeks | Participant responses based on questions posed in an interview |
Countries
Sweden
Contacts
CONTACTBenjamin Bohman
CONTACTNathalie Petersén
PRINCIPAL_INVESTIGATORBenjamin Bohman
Karolinska Institutet
Outcome results
None listed